Ignite Creation Date:
2024-05-06 @ 8:29 AM
Last Modification Date:
2024-10-26 @ 12:00 PM
Study NCT ID:
NCT02747004
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2016-04-19
Brief Title:
A Study of Abemaciclib LY2835219 Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2016-04-19
First Submit QC Date:
April 19 2016
Study First Post Date:
2016-04-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-07-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-20
Last Update Post Date:
2024-06-21
Last Update Post Date Type:
ACTUAL